American Well (AMWL) Scheduled to Post Quarterly Earnings on Wednesday

American Well (NYSE:AMWL - Get Free Report) is set to post its quarterly earnings results after the market closes on Wednesday, May 1st. Analysts expect American Well to post earnings of ($0.18) per share for the quarter. American Well has set its FY 2025 guidance at EPS and its FY 2024 guidance at EPS.Individual that are interested in participating in the company's earnings conference call can do so using this link.

American Well (NYSE:AMWL - Get Free Report) last announced its quarterly earnings results on Wednesday, February 14th. The company reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.19) by $0.02. The company had revenue of $70.68 million for the quarter, compared to analyst estimates of $70.16 million. American Well had a negative net margin of 260.63% and a negative return on equity of 40.19%. American Well's revenue for the quarter was down 10.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.22) EPS. On average, analysts expect American Well to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

American Well Stock Down 2.1 %

Shares of AMWL traded down $0.01 during mid-day trading on Wednesday, reaching $0.53. The company had a trading volume of 2,570,854 shares, compared to its average volume of 1,952,166. The firm has a fifty day simple moving average of $0.88 and a 200-day simple moving average of $1.09. American Well has a fifty-two week low of $0.50 and a fifty-two week high of $2.74.

Analysts Set New Price Targets

Separately, Morgan Stanley reduced their target price on shares of American Well from $1.75 to $1.00 and set an "equal weight" rating on the stock in a report on Monday, April 15th.

Insider Activity at American Well

In other American Well news, CFO Robert Shepardson sold 319,214 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares in the company, valued at approximately $3,101,211.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other American Well news, CFO Robert Shepardson sold 319,214 shares of the business's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $1.09, for a total value of $347,943.26. Following the transaction, the chief financial officer now owns 2,845,148 shares in the company, valued at approximately $3,101,211.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Vukasin Paunovich sold 251,323 shares of the business's stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $1.09, for a total transaction of $273,942.07. Following the completion of the transaction, the executive vice president now owns 2,535,635 shares in the company, valued at approximately $2,763,842.15. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,169,038 shares of company stock worth $1,267,410. 12.94% of the stock is currently owned by corporate insiders.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.